While some academics have called for compensation for assessing other scientists’ work, publishers haven’t warmed to the idea.

COVID-19 has laid bare some of the pitfalls of the relationship between scientific experts and policymakers—but some researchers say there are ways to make it better.

Life sciences professors and other staff make contingency plans for more coronavirus-related disruptions in the coming school year.

Early career researchers face unique challenges when a senior collaborator becomes embroiled in allegations of scientific malpractice.

Speaking a common language is key to a well-integrated team, but guidance is sparse on what—if anything—principal investigators should do about it.

Many preclinical studies carried out in vivo are poorly designed and generate irreproducible data, but efforts to address the problem are on the rise.

Diversity programs are shifting their focus from just providing academic support to creating a learning environment that is more inclusive of people of different backgrounds.

For many, it’s not a question of when senior academics should leave their posts, it’s about how to distribute scarce resources such as grants and faculty positions more fairly.

Scientists are working to maximize the benefits and minimize the costs of sharing.